These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27387761)

  • 1. Circulating tumor cells in the blood of poorly differentiated nasal squamous cell carcinoma patients: correlation with treatment response.
    Li F; Liu J; Song D; Zhang Q; Ding N; He X
    Acta Otolaryngol; 2016 Nov; 136(11):1164-1167. PubMed ID: 27387761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
    Fu X; Shen C; Wang H; Chen F; Li G; Wen Z
    BMC Cancer; 2017 Jul; 17(1):479. PubMed ID: 28693532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma.
    Zhang J; Shi H; Jiang T; Liu Z; Lin PP; Chen N
    BMC Cancer; 2018 Nov; 18(1):1133. PubMed ID: 30454007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cells: a valuable indicator for locally advanced nasopharyngeal carcinoma.
    Liu T; Liu J; Wang G; Chen C; He L; Wang R; Ouyang C
    Eur Arch Otorhinolaryngol; 2024 Sep; 281(9):4963-4972. PubMed ID: 38733533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.
    Wang Z; Cui K; Xue Y; Tong F; Li S
    Med Oncol; 2015 May; 32(5):164. PubMed ID: 25895596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of circulating tumor cells and their expression of cyclooxygenase-2 in patients with nasopharyngeal carcinoma.
    Xie XQ; Luo Y; Ma XL; Li SS; Liu L; Zhang H; Li P; Wang F
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6951-6961. PubMed ID: 31486495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peripheral blood circulating tumor cells in local advanced head and neck squamous cell carcinoma].
    Lou JL; Guo L; Zheng WH; Zhao JZ; Zhao JQ; Liang Z; Wang SY; Fang MY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 52(11):824-829. PubMed ID: 29141291
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy.
    Vo JH; Nei WL; Hu M; Phyo WM; Wang F; Fong KW; Tan T; Soong YL; Cheah SL; Sommat K; Low H; Ling B; Ng J; Tan WL; Chan KS; Oon L; Ying JY; Tan MH
    Sci Rep; 2016 Dec; 6(1):13. PubMed ID: 28442757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cells in patients with head and neck squamous cell carcinoma: Feasibility of detection and quantitation.
    Kawada T; Takahashi H; Sakakura K; Ida S; Mito I; Toyoda M; Chikamatsu K
    Head Neck; 2017 Nov; 39(11):2180-2186. PubMed ID: 28815839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasopharyngeal carcinoma in children and adolescents in an endemic area: a report of 185 cases.
    Yan Z; Xia L; Huang Y; Chen P; Jiang L; Zhang B
    Int J Pediatr Otorhinolaryngol; 2013 Sep; 77(9):1454-60. PubMed ID: 23830224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-2-microglobulin (beta 2M) as a tumor marker in nasopharyngeal carcinoma.
    Lee JK; Tsai SC; Hsieh JF; Ho YJ; Sun SS; Kao CH
    Anticancer Res; 2000; 20(6C):4765-8. PubMed ID: 11205215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of surgical intervention on circulating tumor cells in patients with squamous cell carcinoma of the head and neck using a negative enrichment technology.
    Jatana KR; Balasubramanian P; McMullen KP; Lang JC; Teknos TN; Chalmers JJ
    Head Neck; 2016 Dec; 38(12):1799-1803. PubMed ID: 27265898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of Circulating Tumor Cells in Peripheral Blood of Patients with Esophageal Squamous Cell Carcinoma.
    Matsushita D; Uenosono Y; Arigami T; Yanagita S; Nishizono Y; Hagihara T; Hirata M; Haraguchi N; Arima H; Kijima Y; Kurahara H; Maemura K; Okumura H; Ishigami S; Natsugoe S
    Ann Surg Oncol; 2015 Oct; 22(11):3674-80. PubMed ID: 25652049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of serum copper and zinc levels in patients with nasopharyngeal carcinoma by radiotherapy.
    Hsu HY; Lin SY; Huang CJ; Lian SL; Ho YH
    Biol Trace Elem Res; 1994; 46(1-2):1-13. PubMed ID: 7888274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue polypeptide specific antigen (TPS) as a tumor marker in nasopharyngeal carcinoma.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Anticancer Res; 2000; 20(6C):4661-3. PubMed ID: 11205197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma.
    Zhao L; Tang M; Hu Z; Yan B; Pi W; Li Z; Zhang J; Zhang L; Jiang W; Li G; Qiu Y; Hu F; Liu F; Lu J; Chen X; Xiao L; Xu Z; Tao Y; Yang L; Bode AM; Dong Z; Zhou J; Fan J; Sun L; Cao Y
    Oncotarget; 2015 Jun; 6(18):15995-6018. PubMed ID: 26201446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of peripheral blood circulating tumor cells in oral squamous cell carcinoma and its clinical significance.
    Zhang SY; Qin S; Li GH; Yi YQ; Fu HJ; Gao YJ; Sun ML
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Oct; 39(5):591-597. PubMed ID: 34636209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: development and validation in 3,237 patients from a single institution.
    Chang H; Gao J; Xu BQ; Guo SP; Lu RB; Li G; Huang SM; Han F; Liu ZG; Tao YL; Tu ZW; Chen C; Li XH; Xia YF
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):639-46. PubMed ID: 23910226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and prognostic analysis of second primary squamous cell carcinoma of the tongue after radiotherapy for nasopharyngeal carcinoma.
    Sun C; Hu Z; Zhong Z; Jiang Y; Sun R; Fei J; Xi Y; Li X; Song M; Li W; Li Q
    Br J Oral Maxillofac Surg; 2014 Oct; 52(8):715-20. PubMed ID: 25085271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.
    Zhang L; Tang LQ; Chen QY; Liu H; Guo SS; Liu LT; Guo L; Mo HY; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Shao JY; Sun Y; Ma J; Hong MH; Mai HQ
    Oncotarget; 2016 Feb; 7(5):6221-30. PubMed ID: 26716900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.